Chronic Oral Administration of Aluminum Hydroxide Stimulates Systemic Inflammation and Redox Imbalance in BALB/c Mice

Table 3

Inflammatory markers in the lung, liver, kidney, and small intestine of investigated groups.

	CG	VG	AHG
Lung
CCL2 (pg/mL)			^a
IL-10 (pg/mL)
IL-6 (pg/mL)
Liver
CCL2 (pg/mL)
IL-10 (pg/mL)			^a
IL-6 (pg/mL)
Kidney
CCL2 (pg/mL)
IL-10 (pg/mL)
IL-6 (pg/mL)
Small Intestine
CCL2 (pg/mL)
IL-10 (pg/mL)			^a
IL-6 (pg/mL)			^a

CG: control group; VG: vehicle group; AHG: aluminum hydroxide group; CCL2: monocyte chemotactic protein-1; IL-6: interleukin 6; IL-10: interleukin 10. The letter (a) represents a significant difference between groups when compared to CG. The letter (b) represents a significant difference between groups when compared to VG. Data were expressed as deviation and were analyzed by one-way ANOVA followed by Tukey’s posttest, 6 animals per group.